Background: Gastric cancer metastasis to the lung can rarely manifest as solitary pulmonary nodule. The surgical strategies are different between metastasis from gastric cancer and primary lung cancer; therefore, the clinical prediction of solitary pulmonary nodule is important. Methods: Between September 2006 and September 2016, 38 patients with a history of curative resection for gastric cancer who subsequently underwent lung resection for solitary pulmonary nodule at our institution were evaluated. We retrospectively reviewed clinical characteristics in order to investigate clinical predictors for diagnosis and appropriate operative strategies. Results: Nodules were shown to be 9 metastasis from gastric cancer, 26 primary lung cancer and 3 benign tumors. Between metastasis from gastric cancer and primary lung cancer, there was a significant difference in age (P = 0.013), surgical procedure used for gastrectomy (P = 0.018) and pathological stage of gastric cancer (P = 0.031). All eight patients who had undergone endoscopic resection for gastric cancer and all 10 patients whose pulmonary nodules were detected more than 5 years after gastrectomy were diagnosed as primary lung cancer. Regarding the prognosis after lung resection, at a median follow-up of 29.3 months, the median survival time in patients with metastasis from gastric cancer was 19.7 months (range, 10.2-63.7 months), whereas that was not reached in patients with primary lung cancer. Conclusions: Solitary pulmonary nodule in patients with a history of pathological stage I gastric cancer may be suspected as primary lung cancer, and an anatomical lung resection should be considered positively. In the case of solitary pulmonary nodule suspected metastasis from gastric cancer from clinical characteristics, a limited resection may be considered, and metastasectomy can potentially result in long-term survival.
Introduction
Solitary pulmonary nodule (SPN) in patients with a history of gastric cancer requires preoperative differentiation between metastasis from gastric cancer (MGC) and primary lung cancer (PLC) because the surgical strategies are different between them. PLC requires anatomical lung resection with systematic nodal dissection unless there are contraindications, whereas the role of lung metastasectomy for MGC is still unclear. Gastric cancer metastasis to the lung can rarely manifest as an SPN (1) (2) (3) (4) (5) (6) . SPN of MGC has spicules and cavities as well as PLC, and it is difficult to distinguish them from radiological findings alone (7, 8) . Therefore, the purpose of this study was to investigate clinical predictors for diagnosis and appropriate operative strategies for SPN in patients with gastric cancer.
Materials and methods
A total of 114 patients with a history of curative resection for gastric cancer underwent lung resection for SPN at our institution between September 2006 and September 2016. The SPN was radiologically defined as a unilateral single intraparenchymal lung lesion and was not associated with atelectasis or adenopathy (9) . Sixty-one patients who had insufficient data of gastric cancer (n = 48) or a history of cancer of other organs (n = 13) were excluded from the study. We also excluded 15 patients whose nodules had ground-glass opacity, because this was an evidence of adenocarcinoma of PLC. Finally, the clinical data of 38 patients were eligible for our study (Fig. 1) .
The representative computed tomography (CT) findings of MGC are presented in Fig. 2 . The nodules of MGC had spicules and cavities as well as PLC and were unable to be distinguished from radiological findings alone.
The medical records of each patient were reviewed with regard to clinical characteristics including age, gender, smoking history, tumor solid size, serum carcinoembryonic antigen (CEA) level, SUVmax on positron emission tomography (PET), surgical procedure used for gastrectomy, pathological N status, pathological stage of gastric cancer, history of extrapulmonary metastasis before lung resection, disease-free interval (DFI), timing of gastric cancer and SPN detection, transbronchial lung biopsy (TBLB), percutaneous fine-needle CT-guided lung biopsy and preoperative definitive diagnosis. The DFI was measured during the months between the date of gastric cancer resection and that of SPN detection. We attempted to measure their tumor doubling time (TDT), which might be a predictive factor to differentiate them; however, most PLCs performed operation after a single CT scan. Therefore, we could not review their TDT. Also, the data of adjuvant chemotherapy after gastrectomy were not completely obtained. Post-operative patient characteristics were evaluated in terms of surgical procedure, immunohistochemical staining, histology and chemotherapy after lung metastasectomy. Pathological evaluation of surgical specimen was performed using hematoxylin and eosin staining and compared with previous specimen slides of resected gastric cancer using additional immunohistochemical staining for markers of thyroid transcription factor 1, cytokeratin (CK)-7, CK-20, CK-5/6 and surfactant protein A (2,7). All available survival data were updated in December 2017.
Differences in the categorical variables were compared using Fisher's exact test and Mann-Whitney U tests. The post-operative survival rate was analyzed by the Kaplan-Meier method, and the differences in survival rates were assessed by the log-rank test. All P values were reported using two-tailed analyses, and those <0.05 were considered statistically significant. All statistical analyses were performed with R for Mac version 3.1.2 (R Foundation for statistical computing, Vienna, Austria. URL: http://www.r-project.org).
Results
From the surgical lung specimens, 9 of the 38 patients were diagnosed as MGC, 26 as PLC and 3 as benign tumor (granuloma in 2, smooth muscle cell hyperplasia in 1). Patient characteristics of MGC and PLC are summarized in Table 1 . There were across-group differences in age (P = 0.013), the surgical procedure used for gastrectomy (P = 0.018) and pathological stage of gastric cancer (P = 0.031). All eight patients who had undergone endoscopic resection for gastric cancer were diagnosed as PLC. Also, all 10 patients whose nodules were detected more than 5 years after gastrectomy and all 7 patients whose nodules were detected simultaneously with gastric cancer were also diagnosed as PLC. There were no significant differences between MGC and PLC in terms of gender, smoking history, tumor solid size, serum CEA level, SUVmax on PET, pathological N status, history of extrapulmonary metastasis before lung resection and DFI.
Preoperative biopsy was attempted in 15 patients (39.5%), but 23 patients did not undergo it because of tumor location, size or other reasons. Eight nodules proved to be squamous cell carcinoma of PLC, and four nodules resulted to be affected by an adenocarcinoma (not specified if primary or metastatic); in three nodules, cytology resulted negative for tumor cells. After all, pathologic diagnosis had not been confirmed in 30 patients (78.9%).
Post-operative patient clinicopathological characteristics are summarized in Table 2 . For indeterminate pulmonary nodules, we performed frozen-section diagnosis during surgery in order to determine surgical procedure. We performed frozen-section diagnosis in 28 patients; however, only four patients received instant diagnosis because diagnosis was difficult in the cases of adenocarcinoma. For two nodules, it was not performed due to unknown reasons. Post-operative evaluation for definitive diagnosis is sometimes necessary using immunohistochemical staining, and we performed this staining in 13 patients. Finally, six tumors considered as PLCs before surgery were proven to be MGCs, with one case showing just the opposite. Histological classification of lung adenocarcinoma was lepidic predominant in three patients, papillary predominant in two, acinar predominant in two and solid predominant in six.
To evaluate the prognostic impact, we analyzed median overall survival after lung resection with a median follow-up of 29.3 months. The survival curves are shown in Fig. 3 . The median survival time after lung resection in patients with MGC was 19.7 months (range, 10.2-63.7 months), whereas that was not reached in patients with PLC. The overall 2-year survival rate after lung resection was 33.3% in patients with MGC and 69.2% in patients with PLC. Among nine patients with MGC, there were no statistically significant prognostic factors for post-metastasectomy survival. Four patients (44.7%) had no recurrences after lung resection with a median follow-up of 41.4 months (range, 17.2-63.7 months). Recurrence developed in five patients, and four of them occurred within 1 year after lung resection. The patterns of recurrence were lung metastases in three patients, intracranial metastasis in one and liver metastasis in one. Five patients were alive and four deaths were attributed to disease progression at the last follow-up.
Discussion
PLC is one of the most frequent secondary malignancies that follow gastric cancer surgery (7). However, a pulmonary MGC is less common as a recurrence. Gastric cancer metastases often occur in the liver or abdominal lymph nodes (1), and the incidence of pulmonary metastases ranges from 0.5% to 16% (2,3). Moreover, pulmonary metastases often occur as lymphangitic carcinomatosis or numerous nodules (1, 4, 5) , and only 0.1-6% of patients with metastases develop SPN (1,3,6 ). The surgical strategies are different between MGC and PLC; therefore, preoperative diagnosis between them would be promising for stratifying the treatment strategy.
According to previous reports, MGCs were often misdiagnosed as PLCs before lung resection because of their similar radiological findings (1,7). Several researchers evaluated the CT features of the metastatic tumor including MGC to distinguish from PLCs (8, 10, 11) . They remarked the internal structure and margin of the tumor, including spicule, notching, pleural indentation and pleural vascular involvement, but there were no significant differences observed. Therefore, the authors concluded that the differential diagnosis between MGC and PLC was not possible from radiological findings alone (7, 8) .
Of the clinical characteristics studied, there was a significant difference between MGC and PLC in age, surgical procedure used for gastrectomy and pathological stage of gastric cancer. The median age in patients with MGC is lower than that in patients with PLC, and we conceive that this is because gastric cancer develops in young patients compared with lung cancer in Japan. In terms of surgical procedure used for gastrectomy, eight patients who underwent endoscopic resection for gastric cancer may make a difference between two groups. Regarding pathological stage, it is reasonable that in the early stage of gastric cancer, metastases may not occur often. From our results, SPN of patients with pathological stage I gastric cancer may be suspected as PLC. Interestingly, among patients with MGC, the recurrences after gastrectomy were considered to mainly occur within the first 2 years (2,3) ; however, four of nine MGCs developed more than 2 years after gastrectomy. Among patients with PLC, on the other hand, 7 of 26 PLCs were detected simultaneously with gastric cancer. These are the reasons why there were no significant differences between two groups in DFI. We conclude that age, surgical procedure used for gastrectomy and pathological stage of gastric cancer are clinical predictors for diagnosis of SPN in patients with gastric cancer.
Our clinical prediction is useful in determining surgical strategy. As SPN that appears in patient with a history of curative resection for gastric cancer may not always be MGC, a decision in the treatment option should be made only after the pathologic diagnosis is confirmed (7) . TBLB and percutaneous fine-needle CT-guided lung biopsy are helpful, but these procedures highly depend on the experience of the performing physician, tumor location and size (12) . The biopsy would be sometimes difficult, even if possible, small sample specimen would be obscure for differentiation between adenocarcinoma of MGC and PLC (7) . When preoperative histological diagnosis fails, lung resection is typically vital in order to establish a definitive diagnosis and subsequent treatment options. For indeterminate nodules, we perform frozen-section diagnosis during surgery in order to determine surgical procedure, but we should know that it is also difficult (1, 13) . If the nodule is PLC, an anatomical lung resection leads to a good prognosis, and it is important not to miss the effective therapeutic option. If the nodule is suspected to be MGC from clinical characteristics, however, an initially limited resection may be considered. When it is difficult to differentiate between MGC and PLC by frozen-section diagnosis, an anatomical lung resection with systematic nodal dissection is the typical treatment of choice.
Pulmonary MGC are known to be associated with poor prognoses, and the median survival time is reported to be 13 months (14) . Currently, the standard treatment for MGC is not lung metastasectomy but systemic chemotherapy (1-3) ; however, some researchers reported that lung metastasectomy could be an effective therapeutic option in selected patients with MGC (i.e. those who present with a solitary, small lesion and a prolonged DFI) (1) (2) (3) (4) (5) . Among nine patients with MGC in our study, the median survival time after lung resection was 19.7 months, which was better than that in those treated with chemotherapy. Moreover, our series included four patients who had no recurrences after lung metastasectomy. We could not reach a conclusion because of the small number of cases, however, our study suggested that metastasectomy for SPN of MGC can potentially result in long-term survival. It may be considered if systemic examination reveals no metastasis except SPN. In our study, early recurrences after lung metastasectomy occurred in some patients, and further studies for indication are warranted.
There are some limitations of the present study. First, this study was a retrospective design that used data acquired at our single institution, and the number of patients included was so small that the statistical power to detect a difference in this cohort may be limited. Because of the small number of events, we could not perform multivariate analysis and only performed univariate analysis. Second, there was certainly selection biases because the patients enrolled in our study were only surgical candidates. The patients without surgical indication were not reviewed in this study, and we did not comprehend all the patients who developed pulmonary recurrence after a curative resection for gastric cancer.
In conclusion, we should consider the differential diagnosis for SPN in patients with gastric cancer and determine the appropriate operative strategy. SPN in patients with a history of pathological stage I gastric cancer may be suspected as PLC, and an anatomical lung resection with systematic nodal dissection should be considered positively. In the case of SPN-suspected MGC from clinical characteristics, an initially limited resection may be considered if systemic examination reveals no metastasis except SPN. Metastasectomy for SPN of MGC can potentially result in long-term survival.
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